Outcome of HER2 Testing by FISH applying ASCO/CAP 2007 and 2013 guideline in IHC equivocal group of breast cancer: Experience at tertiary cancer care centre

BACKGROUND AND OBJECTIVES: HER2 testing guideline of ASCO/CAP for interpretation and reporting has recently been revised. The study is aimed to measure the impact of 2013 CAP guideline on equivocal HER2 test outcome (immunohistochemistry [IHC] 2+) when tested by fluorescent in situ hybridization (FI...

Descripción completa

Detalles Bibliográficos
Autores principales: Panigrahi, Manoj Kumar, Kumar, Dushyant, Mehta, Anurag, Saikia, Kandarpa Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
ORIGINAL ARTICLE: Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506804/
https://www.ncbi.nlm.nih.gov/pubmed/28702401
http://dx.doi.org/10.4103/2278-330X.208841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506804/
https://www.ncbi.nlm.nih.gov/pubmed/28702401
http://dx.doi.org/10.4103/2278-330X.208841

Ejemplares similares